01 SKHY US SK hynix Inc. · 137.91 USD · pulse 85.7 first scan new 83.4 Strong
Product & Moat w=20%68.9
Gross margin (pricing power)70.2%100
Revenue CAGR (3y)29.6%100
Operating margin trend+33.3pp over 3y100
R&D intensity (innovation)6.7%44.4
Margin stabilitysd 23.2pp0
Valuation w=20%100
Forward P/E4.3100
PEG ratio0.30100
Management w=15%63.8
Return on equity92.7%100
Buybacks vs dilution+0.7%/yr share count55.4
Net debt / EBITDA-0.5100
Insider ownership0.0%0
Financial Health w=15%100
Current ratio17.5100
Debt / equity0.07100
Interest coverage55.6x100
Cash vs total debt4.73x100
Marketing & Brand w=10%100
Revenue growth (yoy)256.8%100
SG&A efficiency50.7x revenue/SG&A100
Brand pricing premium70.2%100
Momentumno data
News & Sentiment w=10%87.5
Analyst consensus (1=buy)1.4100
Analyst target upside77.4%100
Earnings surprises (avg)+86.1%100
Headline tone2 pos / 2 neg of 1050
02 TSM US Taiwan Semiconductor Manufactur · 420.04 USD · pulse 84.9 first scan new 81.7 Strong
Product & Moat w=20%74.8
Gross margin (pricing power)64.2%100
Revenue CAGR (3y)18.9%94.7
Operating margin trend+1.3pp over 3y63
R&D intensity (innovation)6.5%43.1
Margin stabilitysd 2.3pp73.4
Valuation w=20%92
Forward P/E19.477.5
PEG ratio1.0190.5
FCF yield33.9%100
EV / EBITDA4.7100
Management w=15%54.4
Return on equity40.0%100
Buybacks vs dilution+0.0%/yr share count66.6
Net debt / EBITDA-0.8100
Insider ownership0.0%0.4
FCF conversion0.44x net income5.1
Financial Health w=15%100
Current ratio2.5100
Debt / equity0.15100
Interest coverage166.0x100
Cash vs total debt3.58x100
Marketing & Brand w=10%99.4
Revenue growth (yoy)36.0%100
SG&A efficiency38.4x revenue/SG&A100
Brand pricing premium64.2%98.1
Momentum w=10%88
Price vs 200-day MA+17.0%100
52-week range position77th pct84
6m strength vs S&P 500+9.0pp80
News & Sentiment w=10%95.9
Analyst consensus (1=buy)1.4100
Analyst target upside28.6%96.5
Earnings surprises (avg)+8.1%87.2
Headline tone3 pos / 0 neg of 10100
03 ANET US Arista Networks, Inc. · 188.67 USD · pulse 81.9 first scan new 81.5 Strong
Product & Moat w=20%97
Gross margin (pricing power)63.0%100
Revenue CAGR (3y)27.1%100
Operating margin trend+8.0pp over 3y100
R&D intensity (innovation)13.7%91.6
Margin stabilitysd 1.3pp93.4
Valuation w=20%22.2
Forward P/E36.725.2
PEG ratio2.0543
FCF yield1.6%20.6
EV / EBITDA48.40
Management w=15%90.7
Return on equity31.5%100
Buybacks vs dilution+0.8%/yr share count53.7
Net debt / EBITDA-2.9100
Insider ownership17.2%100
FCF conversion1.11x net income100
Financial Health w=15%100
Current ratio3.0100
Interest coverageno net interest expense100
Cash vs total debtdebt-free100
Marketing & Brand w=10%98.3
Revenue growth (yoy)37.7%100
SG&A efficiency13.3x revenue/SG&A100
Brand pricing premium63.0%95
Momentum w=10%99.7
Price vs 200-day MA+28.3%100
52-week range position89th pct99.2
6m strength vs S&P 500+25.2pp100
News & Sentiment w=10%96.2
Analyst consensus (1=buy)1.3100
Analyst target upside26.5%91.2
Earnings surprises (avg)+9.0%93.4
Headline tone8 pos / 0 neg of 10100
04 META US Meta Platforms, Inc. · 592.1 USD · pulse 72.1 first scan new 81 Strong
Product & Moat w=20%98.2
Gross margin (pricing power)81.7%100
Revenue CAGR (3y)19.9%99.5
Operating margin trend+16.6pp over 3y100
R&D intensity (innovation)28.5%100
Margin stabilitysd 1.4pp91.4
Valuation w=20%67.8
Forward P/E16.985.3
PEG ratio0.8896.2
FCF yield1.4%16.9
EV / EBITDA14.072.9
Management w=15%56.2
Return on equity29.8%100
Buybacks vs dilution-1.1%/yr share count84.8
Net debt / EBITDA0.295
Insider ownership0.1%1.4
FCF conversion0.36x net income0
Financial Health w=15%83.4
Current ratio2.2100
Debt / equity0.4387.2
Interest coverage74.8x100
Cash vs total debt0.80x46.4
Marketing & Brand w=10%100
Revenue growth (yoy)28.0%100
SG&A efficiency8.3x revenue/SG&A100
Brand pricing premium81.7%100
Momentum w=10%18.4
Price vs 200-day MA-6.1%35.7
52-week range position26th pct19.4
6m strength vs S&P 500-22.3pp0
News & Sentiment w=10%60.9
Analyst consensus (1=buy)1.4100
Analyst target upside27.8%94.6
Earnings surprises (avg)+2.4%49.1
Headline tone0 pos / 1 neg of 100
05 GOOG US Alphabet Inc. · 353.47 USD · pulse 79.1 first scan new 80.2 Strong
Product & Moat w=20%90.1
Gross margin (pricing power)60.9%100
Revenue CAGR (3y)12.5%62.6
Operating margin trend+5.6pp over 3y100
R&D intensity (innovation)15.2%100
Margin stabilitysd 1.6pp87.8
Valuation w=20%45
Forward P/E24.063.7
PEG ratio1.0290.1
FCF yield0.5%0.4
EV / EBITDA24.425.6
Management w=15%73.2
Return on equity48.7%100
Buybacks vs dilution-2.0%/yr share count100
Net debt / EBITDA-0.7100
Insider ownership6.6%66
FCF conversion0.17x net income0
Financial Health w=15%100
Current ratio2.7100
Debt / equity0.19100
Interest coverage216.8x100
Cash vs total debt2.01x100
Marketing & Brand w=10%95.5
Revenue growth (yoy)24.2%96.8
SG&A efficiency8.0x revenue/SG&A100
Brand pricing premium60.9%89.7
Momentum w=10%72.3
Price vs 200-day MA+7.8%91
52-week range position77th pct84.1
6m strength vs S&P 500-2.5pp41.7
News & Sentiment w=10%93.3
Analyst consensus (1=buy)1.4100
Analyst target upside19.3%73.3
Earnings surprises (avg)+85.2%100
Headline tone2 pos / 0 neg of 10100
06 AMD US Advanced Micro Devices, Inc. · 483.36 USD · pulse 76.5 first scan new 74.6 Good
Product & Moat w=20%87.5
Gross margin (pricing power)55.7%89.3
Revenue CAGR (3y)13.6%68.2
Operating margin trend+5.3pp over 3y100
R&D intensity (innovation)23.4%100
Margin stabilitysd 2.0pp80
Valuation w=20%34.6
Forward P/E31.341.6
PEG ratio1.1285.6
FCF yield1.1%11.3
EV / EBITDA81.60
Management w=15%61.1
Return on equity10.2%40.8
Buybacks vs dilution+0.4%/yr share count60.5
Net debt / EBITDA-0.9100
Insider ownership0.4%4
FCF conversion2.04x net income100
Financial Health w=15%100
Current ratio2.6100
Debt / equity0.06100
Interest coverage32.6x100
Cash vs total debt3.07x100
Marketing & Brand w=10%92.3
Revenue growth (yoy)50.1%100
SG&A efficiency8.4x revenue/SG&A100
Brand pricing premium55.7%76.8
Momentum w=10%94.7
Price vs 200-day MA+51.9%100
52-week range position77th pct84.1
6m strength vs S&P 500+119.9pp100
News & Sentiment w=10%92.2
Analyst consensus (1=buy)1.5100
Analyst target upside25.8%89.6
Earnings surprises (avg)+6.9%79.1
Headline tone2 pos / 0 neg of 10100
07 NVDA US NVIDIA Corporation · 223.96 USD · pulse 76.4 first scan new 73.5 Good
Product & Moat w=20%71.4
Gross margin (pricing power)74.1%100
Revenue CAGR (3y)100.0%100
Operating margin trend+39.7pp over 3y100
R&D intensity (innovation)8.6%57.1
Margin stabilitysd 7.1pp0
Valuation w=20%47.5
Forward P/E17.483.7
PEG ratio0.55100
FCF yield0.9%6.4
EV / EBITDA32.50
Management w=15%62.9
Return on equity114.3%100
Buybacks vs dilution-0.5%/yr share count74.8
Net debt / EBITDA-0.2100
Insider ownership4.0%39.9
FCF conversion0.39x net income0
Financial Health w=15%100
Current ratio3.4100
Debt / equity0.07100
Interest coverage547.1x100
Cash vs total debt4.15x100
Marketing & Brand w=10%100
Revenue growth (yoy)85.2%100
SG&A efficiency47.2x revenue/SG&A100
Brand pricing premium74.1%100
Momentum w=10%90.6
Price vs 200-day MA+15.6%100
52-week range position84th pct92.1
6m strength vs S&P 500+8.9pp79.7
News & Sentiment w=10%91
Analyst consensus (1=buy)1.3100
Analyst target upside35.2%100
Earnings surprises (avg)+4.6%64
Headline tone3 pos / 0 neg of 10100
08 MU US Micron Technology, Inc. · 877.57 USD · pulse 77.6 first scan new 73.2 Good
Product & Moat w=20%40.3
Gross margin (pricing power)72.6%100
Revenue CAGR (3y)6.7%33.6
Operating margin trend-5.3pp over 3y0
R&D intensity (innovation)10.2%67.7
Margin stabilitysd 21.2pp0
Valuation w=20%90.5
Forward P/E5.7100
PEG ratio0.13100
EV / EBITDA14.271.6
Management w=15%65.2
Return on equity66.6%100
Buybacks vs dilution+0.8%/yr share count52.6
Net debt / EBITDA-0.3100
Insider ownership0.3%2.6
FCF conversion0.89x net income70.7
Financial Health w=15%100
Current ratio3.4100
Debt / equity0.06100
Interest coverage21.2x100
Cash vs total debt4.08x100
Marketing & Brand w=10%100
Revenue growth (yoy)345.7%100
SG&A efficiency31.0x revenue/SG&A100
Brand pricing premium72.6%100
Momentum w=10%91.4
Price vs 200-day MA+64.1%100
52-week range position69th pct74.3
6m strength vs S&P 500+110.5pp100
News & Sentiment w=10%75
Analyst consensus (1=buy)1.4100
Analyst target upside71.8%100
Earnings surprises (avg)+20.2%100
Headline tone0 pos / 2 neg of 100
09 MS US ⚠ 1 Morgan Stanley · 216.33 USD · pulse 74.2 first scan new 71.9 Good
Product & Moat w=20%73.8
Gross margin (pricing power)87.6%100
Revenue CAGR (3y)9.5%47.6
Valuation w=20%65.6
Forward P/E15.988.3
PEG ratio2.0642.9
Management w=15%89.9
Return on equity18.0%71.9
Buybacks vs dilution-1.9%/yr share count97.8
Insider ownership24.4%100
Financial Health w=15%59.4
Current ratio2.099.9
Debt / equity5.170
Cash vs total debt1.22x78.2
Marketing & Brand w=10%67.7
Revenue growth (yoy)28.0%100
SG&A efficiency2.2x revenue/SG&A3
Brand pricing premium87.6%100
Momentum w=10%92.8
Price vs 200-day MA+17.7%100
52-week range position87th pct96.8
6m strength vs S&P 500+9.5pp81.7
News & Sentiment w=10%78.9
Analyst consensus (1=buy)2.367.2
Analyst target upside9.4%48.4
Earnings surprises (avg)+18.4%100
Headline tone3 pos / 1 neg of 10100
⚠ Red flags
Heavy leverage (D/E 5.2)
10 ASML US ASML Holding N.V. - New York Re · 1,740.99 USD · pulse 73 first scan new 71.7 Good
Product & Moat w=20%88.9
Gross margin (pricing power)52.7%81.8
Revenue CAGR (3y)15.6%77.8
Operating margin trend+3.9pp over 3y88.9
R&D intensity (innovation)14.4%95.9
Margin stabilitysd 0.8pp100
Valuation w=20%26.9
Forward P/E29.447.3
PEG ratio1.9846.4
FCF yield1.3%13.9
EV / EBITDA2,753.90
Management w=15%69.6
Return on equity53.9%100
Buybacks vs dilution-0.8%/yr share count79.7
Net debt / EBITDA-0.4100
Insider ownership0.0%0.1
FCF conversion0.88x net income68.3
Financial Health w=15%86.1
Current ratio1.344.5
Debt / equity0.09100
Interest coverage97.4x100
Cash vs total debt3.82x100
Marketing & Brand w=10%84.8
Revenue growth (yoy)21.3%85.2
SG&A efficiency26.0x revenue/SG&A100
Brand pricing premium52.7%69.3
Momentum w=10%92.5
Price vs 200-day MA+23.9%100
52-week range position81th pct88.3
6m strength vs S&P 500+11.8pp89.3
News & Sentiment w=10%87.5
Analyst consensus (1=buy)1.4100
Analyst target upside25.1%87.8
Earnings surprises (avg)+4.3%62.2
Headline tone5 pos / 1 neg of 10100
11 PLTR US Palantir Technologies Inc. · 172.01 USD · pulse 70.4 first scan new 70.9 Good
Product & Moat w=20%95.2
Gross margin (pricing power)84.8%100
Revenue CAGR (3y)32.9%100
Operating margin trend+40.1pp over 3y100
R&D intensity (innovation)12.5%83.1
Margin stabilitysd 1.4pp93
Valuation w=20%9.8
Forward P/E74.80
PEG ratio2.1538.7
FCF yield0.5%0.4
EV / EBITDA151.80
Management w=15%67
Return on equity38.1%100
Buybacks vs dilution+4.4%/yr share count0
Net debt / EBITDA-3.5100
Insider ownership3.5%34.9
FCF conversion1.33x net income100
Financial Health w=15%100
Current ratio7.2100
Debt / equity0.02100
Interest coverage407.5x100
Cash vs total debt44.51x100
Marketing & Brand w=10%70.1
Revenue growth (yoy)92.8%100
SG&A efficiency2.6x revenue/SG&A10.2
Brand pricing premium84.8%100
Momentum w=10%89
Price vs 200-day MA+13.0%100
52-week range position65th pct68.5
6m strength vs S&P 500+14.6pp98.5
News & Sentiment w=10%84.6
Analyst consensus (1=buy)1.887.5
Analyst target upside10.4%51
Earnings surprises (avg)+17.7%100
Headline tone5 pos / 0 neg of 10100
12 SAP US SAP SE · 206.16 USD · pulse 65.4 first scan new 70 Good
Product & Moat w=20%87.6
Gross margin (pricing power)73.7%100
Revenue CAGR (3y)7.6%38.1
Operating margin trend+5.6pp over 3y100
R&D intensity (innovation)18.0%100
Margin stabilitysd 0.3pp100
Valuation w=20%47.8
Forward P/E21.571.3
PEG ratio1.6959.6
FCF yield3.8%60.4
EV / EBITDA284.90
Management w=15%67.9
Return on equity18.3%73.3
Buybacks vs dilution+0.0%/yr share count66.5
Net debt / EBITDA-0.1100
Insider ownership0.0%0
FCF conversion1.27x net income100
Financial Health w=15%75.6
Current ratio1.129
Debt / equity0.2298.9
Interest coverage21.9x100
Cash vs total debt1.17x74.6
Marketing & Brand w=10%54.2
Revenue growth (yoy)9.4%37.6
SG&A efficiency3.5x revenue/SG&A25
Brand pricing premium73.7%100
Momentum w=10%45.4
Price vs 200-day MA+3.8%75.1
52-week range position42th pct40.6
6m strength vs S&P 500-8.9pp20.4
News & Sentiment w=10%68.1
Analyst consensus (1=buy)1.697.5
Analyst target upside17.8%69.6
Earnings surprises (avg)+3.3%55.5
Headline tone2 pos / 2 neg of 1050
13 MSFT US Microsoft Corporation · 499.99 USD · pulse 69.5 first scan new 68.8 Good
Product & Moat w=20%90.4
Gross margin (pricing power)67.9%100
Revenue CAGR (3y)16.1%80.6
Operating margin trend+5.0pp over 3y100
R&D intensity (innovation)10.7%71.4
Margin stabilitysd 0.6pp100
Valuation w=20%45.8
Forward P/E21.371.8
PEG ratio1.6163.2
FCF yield0.4%0
EV / EBITDA19.448.3
Management w=15%52.2
Return on equity34.0%100
Buybacks vs dilution-0.0%/yr share count67
Net debt / EBITDA0.393.3
Insider ownership0.1%0.9
FCF conversion0.12x net income0
Financial Health w=15%65.3
Current ratio1.235.8
Debt / equity0.2994.9
Interest coverage55.4x100
Cash vs total debt0.60x30.5
Marketing & Brand w=10%90.3
Revenue growth (yoy)17.7%70.8
SG&A efficiency9.6x revenue/SG&A100
Brand pricing premium67.9%100
Momentum w=10%93.5
Price vs 200-day MA+15.8%100
52-week range position79th pct86.5
6m strength vs S&P 500+13.2pp93.9
News & Sentiment w=10%62.1
Analyst consensus (1=buy)1.4100
Analyst target upside12.7%56.7
Earnings surprises (avg)+8.8%91.9
Headline tone0 pos / 3 neg of 100
14 NFLX US Netflix, Inc. · 74.14 USD · pulse 62 first scan new 68.4 Good
Product & Moat w=20%66.8
Gross margin (pricing power)49.1%72.8
Revenue CAGR (3y)12.6%63.2
Operating margin trend+11.7pp over 3y100
R&D intensity (innovation)7.5%50
Margin stabilitysd 3.6pp48
Valuation w=20%69.4
Forward P/E19.477.5
PEG ratio1.6561.5
FCF yield8.2%100
EV / EBITDA21.538.8
Management w=15%77.8
Return on equity49.5%100
Buybacks vs dilution-1.8%/yr share count96
Net debt / EBITDA0.587.2
Insider ownership0.6%5.7
FCF conversion2.31x net income100
Financial Health w=15%58.9
Current ratio1.128.5
Debt / equity0.5580.4
Interest coverage17.4x100
Cash vs total debt0.55x26.8
Marketing & Brand w=10%71.3
Revenue growth (yoy)13.4%53.6
SG&A efficiency8.7x revenue/SG&A100
Brand pricing premium49.1%60.3
Momentum w=10%0.5
Price vs 200-day MA-17.7%0
52-week range position11th pct1.4
6m strength vs S&P 500-21.8pp0
News & Sentiment w=10%70.8
Analyst consensus (1=buy)1.791
Analyst target upside26.8%92.1
Earnings surprises (avg)-5.0%0.3
Headline tone3 pos / 0 neg of 10100
15 AVGO US Broadcom Inc. · 427.76 USD · pulse 71 first scan new 68 Good
Product & Moat w=20%80.8
Gross margin (pricing power)76.3%100
Revenue CAGR (3y)24.4%100
Operating margin trend-2.2pp over 3y28
R&D intensity (innovation)17.2%100
Margin stabilitysd 2.2pp75.8
Valuation w=20%46.3
Forward P/E21.969.9
PEG ratio0.44100
FCF yield1.3%15.2
EV / EBITDA49.40
Management w=15%58.5
Return on equity37.3%100
Buybacks vs dilution+4.3%/yr share count0
Net debt / EBITDA1.173.1
Insider ownership1.9%19.5
FCF conversion1.18x net income100
Financial Health w=15%64.1
Current ratio2.2100
Debt / equity0.7470
Interest coverage8.1x78.7
Cash vs total debt0.30x7.9
Marketing & Brand w=10%100
Revenue growth (yoy)47.9%100
SG&A efficiency15.2x revenue/SG&A100
Brand pricing premium76.3%100
Momentum w=10%92.7
Price vs 200-day MA+16.7%100
52-week range position73th pct78.2
6m strength vs S&P 500+16.9pp100
News & Sentiment w=10%78.8
Analyst consensus (1=buy)1.3100
Analyst target upside23.4%83.5
Earnings surprises (avg)+2.3%48.4
Headline tone2 pos / 1 neg of 1083.3
16 SHOP.TO CA SHOPIFY INC · 211.37 CAD · pulse 65.6 first scan new 67.7 Good
Product & Moat w=20%91.6
Gross margin (pricing power)47.8%69.4
Revenue CAGR (3y)27.3%100
Operating margin trend+28.6pp over 3y100
R&D intensity (innovation)13.3%88.6
Margin stabilitysd 0.8pp100
Valuation w=20%1.6
Forward P/E61.80
PEG ratio2.895
FCF yield0.6%1.4
EV / EBITDA111.60
Management w=15%63.7
Return on equity15.5%62.2
Buybacks vs dilution+0.7%/yr share count54.2
Net debt / EBITDA-2.0100
Insider ownership0.2%2.3
FCF conversion1.29x net income100
Financial Health w=15%100
Current ratio5.4100
Debt / equity0.01100
Interest coverage1639.1x100
Cash vs total debt27.79x100
Marketing & Brand w=10%71.3
Revenue growth (yoy)33.7%100
SG&A efficiency5.4x revenue/SG&A56.9
Brand pricing premium47.8%56.9
Momentum w=10%90.7
Price vs 200-day MA+15.0%100
52-week range position68th pct72.2
6m strength vs S&P 500+26.1pp100
News & Sentiment w=10%61.6
Analyst consensus (1=buy)1.791.8
Analyst target upside-6.4%9.1
Earnings surprises (avg)+1.8%45.6
Headline tone3 pos / 0 neg of 10100
17 V US Visa Inc. · 362.5 USD · pulse 69.2 first scan new 67.3 Good
Product & Moat w=20%74.3
Gross margin (pricing power)97.7%100
Revenue CAGR (3y)10.9%54.6
Operating margin trend-0.8pp over 3y42.4
Margin stabilitysd 0.2pp100
Valuation w=20%51.6
Forward P/E24.263
PEG ratio1.6760.4
FCF yield3.0%45.7
EV / EBITDA21.837.4
Management w=15%76.2
Return on equity61.2%100
Buybacks vs dilution-2.5%/yr share count100
Net debt / EBITDA0.391.9
Insider ownership0.1%0.8
FCF conversion1.02x net income88.2
Financial Health w=15%54.5
Current ratio1.015.4
Debt / equity0.6873.4
Interest coverage45.1x100
Cash vs total debt0.58x29.1
Marketing & Brand w=10%85.9
Revenue growth (yoy)14.4%57.6
SG&A efficiency9.2x revenue/SG&A100
Brand pricing premium97.7%100
Momentum w=10%80.4
Price vs 200-day MA+9.8%99.2
52-week range position89th pct99.3
6m strength vs S&P 500-2.2pp42.5
News & Sentiment w=10%78.2
Analyst consensus (1=buy)1.4100
Analyst target upside14.6%61.5
Earnings surprises (avg)+2.7%51.2
Headline tone3 pos / 1 neg of 10100
18 LRCX US Lam Research Corporation · 311.35 USD · pulse 70.1 first scan new 66.9 Good
Product & Moat w=20%62
Gross margin (pricing power)50.5%76.2
Revenue CAGR (3y)2.3%11.4
Operating margin trend+0.8pp over 3y57.7
R&D intensity (innovation)11.4%75.8
Margin stabilitysd 1.6pp88.9
Valuation w=20%32.3
Forward P/E27.054.5
PEG ratio1.4968.4
FCF yield0.8%6.2
EV / EBITDA44.90
Management w=15%66.6
Return on equity65.1%100
Buybacks vs dilution-2.5%/yr share count100
Net debt / EBITDA-0.2100
Insider ownership0.3%2.7
FCF conversion0.61x net income30.3
Financial Health w=15%98.5
Current ratio2.6100
Debt / equity0.3094.5
Interest coverage34.4x100
Cash vs total debt1.49x99.5
Marketing & Brand w=10%87.9
Revenue growth (yoy)30.0%100
SG&A efficiency18.8x revenue/SG&A100
Brand pricing premium50.5%63.7
Momentum w=10%89.1
Price vs 200-day MA+27.1%100
52-week range position64th pct67.2
6m strength vs S&P 500+23.0pp100
News & Sentiment w=10%87.6
Analyst consensus (1=buy)1.5100
Analyst target upside18.2%70.6
Earnings surprises (avg)+7.0%79.9
Headline tone4 pos / 0 neg of 10100
19 MA US ⚠ 1 Mastercard Incorporated · 562.95 USD · pulse 66.9 first scan new 66.3 Good
Product & Moat w=20%85.5
Gross margin (pricing power)100.0%100
Revenue CAGR (3y)13.8%69.1
Operating margin trend+2.3pp over 3y73
Margin stabilitysd 0.7pp100
Valuation w=20%51.3
Forward P/E24.562.2
PEG ratio1.7556.7
FCF yield3.4%53.4
EV / EBITDA22.832.7
Management w=15%77.3
Return on equity241.2%100
Buybacks vs dilution-2.2%/yr share count100
Net debt / EBITDA0.685.3
Insider ownership0.1%1.1
FCF conversion1.13x net income100
Financial Health w=15%35.7
Current ratio1.121.7
Debt / equity4.400
Interest coverage26.7x100
Cash vs total debt0.47x20.9
Marketing & Brand w=10%78.3
Revenue growth (yoy)14.1%56.4
SG&A efficiency6.7x revenue/SG&A78.6
Brand pricing premium100.0%100
Momentum w=10%62.5
Price vs 200-day MA+6.9%87.6
52-week range position74th pct80.1
6m strength vs S&P 500-9.1pp19.7
News & Sentiment w=10%85.7
Analyst consensus (1=buy)1.4100
Analyst target upside18.0%70.1
Earnings surprises (avg)+5.9%72.6
Headline tone3 pos / 1 neg of 10100
⚠ Red flags
Heavy leverage (D/E 4.4)
20 KLAC US KLA Corporation · 198.11 USD · pulse 66.4 first scan new 65.4 Good
Product & Moat w=20%77.8
Gross margin (pricing power)61.3%100
Revenue CAGR (3y)9.7%48.4
Operating margin trend+1.6pp over 3y65.8
R&D intensity (innovation)11.2%74.6
Margin stabilitysd 0.5pp100
Valuation w=20%26.4
Forward P/E30.244.7
PEG ratio1.8751.4
FCF yield1.0%9.3
EV / EBITDA43.00
Management w=15%66.2
Return on equity87.5%100
Buybacks vs dilution-2.4%/yr share count100
Net debt / EBITDA0.294.8
Insider ownership0.1%1.2
FCF conversion0.65x net income35.2
Financial Health w=15%75.8
Current ratio2.9100
Debt / equity0.9757.3
Interest coverage16.4x100
Cash vs total debt0.80x45.9
Marketing & Brand w=10%83.9
Revenue growth (yoy)15.2%60.8
SG&A efficiency11.8x revenue/SG&A100
Brand pricing premium61.3%90.8
Momentum w=10%84.3
Price vs 200-day MA+20.5%100
52-week range position52th pct53
6m strength vs S&P 500+25.6pp100
News & Sentiment w=10%75
Analyst consensus (1=buy)1.982.8
Analyst target upside16.5%66.3
Earnings surprises (avg)+2.6%50.8
Headline tone4 pos / 1 neg of 10100
21 GS US ⚠ 1 Goldman Sachs Group, Inc. (The) · 1,039.61 USD · pulse 68.5 first scan new 65.2 Good
Product & Moat w=20%67.9
Gross margin (pricing power)82.1%100
Revenue CAGR (3y)7.2%35.8
Valuation w=20%81.1
Forward P/E14.093.8
PEG ratio1.4968.4
Management w=15%57.7
Return on equity16.9%67.6
Buybacks vs dilution-4.0%/yr share count100
Insider ownership0.5%5.4
Financial Health w=15%49.1
Current ratio1.663.6
Debt / equity7.250
Cash vs total debt1.29x83.8
Marketing & Brand w=10%72.1
Revenue growth (yoy)42.5%100
SG&A efficiency3.0x revenue/SG&A16.2
Brand pricing premium82.1%100
Momentum w=10%78.2
Price vs 200-day MA+13.3%100
52-week range position75th pct81.3
6m strength vs S&P 500+1.0pp53.3
News & Sentiment w=10%76.4
Analyst consensus (1=buy)2.656
Analyst target upside9.8%49.5
Earnings surprises (avg)+20.5%100
Headline tone2 pos / 0 neg of 10100
⚠ Red flags
Heavy leverage (D/E 7.3)
22 ARM US Arm Holdings plc · 282.57 USD · pulse 62.9 first scan new 65.2 Good
Product & Moat w=20%80
Gross margin (pricing power)97.5%100
Revenue CAGR (3y)22.5%100
Operating margin trend-6.9pp over 3y0
R&D intensity (innovation)56.4%100
Margin stabilitysd 0.9pp100
Valuation w=20%7.7
Forward P/E92.10
PEG ratio2.3230.9
FCF yield0.4%0
EV / EBITDA280.50
Management w=15%60
Return on equity13.4%53.4
Buybacks vs dilution+1.2%/yr share count45.9
Net debt / EBITDA-3.2100
Insider ownership0.1%0.7
FCF conversion1.48x net income100
Financial Health w=15%100
Current ratio5.3100
Debt / equity0.06100
Interest coverageno net interest expense100
Cash vs total debt8.02x100
Marketing & Brand w=10%76.6
Revenue growth (yoy)22.4%89.6
SG&A efficiency4.4x revenue/SG&A40.2
Brand pricing premium97.5%100
Momentum w=10%84.6
Price vs 200-day MA+46.8%100
52-week range position53th pct53.9
6m strength vs S&P 500+116.4pp100
News & Sentiment w=10%52.3
Analyst consensus (1=buy)1.984
Analyst target upside1.5%28.7
Earnings surprises (avg)+9.4%96.3
Headline tone1 pos / 3 neg of 100
23 CVX US Chevron Corporation · 186.56 USD · pulse 69.8 first scan new 65 Good
Product & Moat w=20%40.2
Gross margin (pricing power)44.3%60.7
Revenue CAGR (3y)-7.9%0
Operating margin trend-7.9pp over 3y0
Margin stabilitysd 0.7pp100
Valuation w=20%98.2
Forward P/E14.492.8
PEG ratio0.75100
FCF yield6.0%99.9
EV / EBITDA7.9100
Management w=15%65.3
Return on equity12.2%48.9
Buybacks vs dilution+1.4%/yr share count43.8
Net debt / EBITDA0.685.9
Insider ownership4.8%47.7
FCF conversion1.78x net income100
Financial Health w=15%60
Current ratio1.337.7
Debt / equity0.19100
Interest coverage17.2x100
Cash vs total debt0.23x2.3
Marketing & Brand w=10%82.7
Revenue growth (yoy)53.5%100
SG&A efficiency36.0x revenue/SG&A100
Brand pricing premium44.3%48.2
Momentum w=10%61.3
Price vs 200-day MA+7.0%87.9
52-week range position65th pct69
6m strength vs S&P 500-6.9pp27
News & Sentiment w=10%89.2
Analyst consensus (1=buy)1.791.2
Analyst target upside16.3%65.7
Earnings surprises (avg)+17.0%100
Headline tone6 pos / 2 neg of 10100
24 LLY US Eli Lilly and Company · 1,185.71 USD · pulse 67.2 first scan new 64.8 Good
Product & Moat w=20%94.6
Gross margin (pricing power)83.4%100
Revenue CAGR (3y)31.7%100
Operating margin trend+16.5pp over 3y100
R&D intensity (innovation)20.5%100
Margin stabilitysd 2.3pp73.2
Valuation w=20%37.6
Forward P/E25.658.7
PEG ratio1.5665.5
FCF yield1.0%9.9
EV / EBITDA26.416.2
Management w=15%58.6
Return on equity102.3%100
Buybacks vs dilution-2.0%/yr share count99.7
Net debt / EBITDA1.172.5
Insider ownership0.2%1.5
FCF conversion0.54x net income19.4
Financial Health w=15%41.8
Current ratio1.446.2
Debt / equity1.6221.1
Interest coverage38.0x100
Cash vs total debt0.16x0
Marketing & Brand w=10%88.2
Revenue growth (yoy)47.7%100
SG&A efficiency5.9x revenue/SG&A64.6
Brand pricing premium83.4%100
Momentum w=10%83.8
Price vs 200-day MA+15.0%100
52-week range position92th pct100
6m strength vs S&P 500+0.4pp51.4
News & Sentiment w=10%85
Analyst consensus (1=buy)1.791.4
Analyst target upside9.4%48.5
Earnings surprises (avg)+20.4%100
Headline tone4 pos / 0 neg of 10100
25 AMZN US Amazon.com, Inc. · 274.48 USD · pulse 68.5 first scan new 62.9 Good
Product & Moat w=20%76.8
Gross margin (pricing power)50.8%76.9
Revenue CAGR (3y)11.7%58.7
Operating margin trend+8.8pp over 3y100
Margin stabilitysd 2.4pp71.5
Valuation w=20%39.9
Forward P/E26.655.8
PEG ratio1.8950.6
FCF yield0.1%0
EV / EBITDA18.353.2
Management w=15%62
Return on equity30.6%100
Buybacks vs dilution+1.6%/yr share count40.6
Net debt / EBITDA0.881
Insider ownership8.9%88.7
FCF conversion0.04x net income0
Financial Health w=15%56.8
Current ratio1.019.4
Debt / equity0.4685.8
Interest coverage43.8x100
Cash vs total debt0.49x22.2
Marketing & Brand w=10%80.9
Revenue growth (yoy)19.6%78.4
SG&A efficiency12.3x revenue/SG&A100
Brand pricing premium50.8%64.4
Momentum w=10%99.5
Price vs 200-day MA+16.0%100
52-week range position89th pct98.5
6m strength vs S&P 500+18.5pp100
News & Sentiment w=10%92.9
Analyst consensus (1=buy)1.3100
Analyst target upside18.7%71.8
Earnings surprises (avg)+77.4%100
Headline tone3 pos / 0 neg of 10100
26 SPCX US ⚠ 1 Space Exploration Technologies · 133.11 USD · pulse 63 first scan new 62.8 Good
Product & Moat w=20%65.8
Gross margin (pricing power)51.9%79.7
Revenue CAGR (2y)34.1%100
Operating margin trend-15.9pp over 2y0
R&D intensity (innovation)46.3%100
Margin stabilitysd 3.5pp49.4
Valuation w=20%0
Forward P/E71.80
EV / EBITDA584.90
Management w=15%100
Net debt / EBITDA-10.2100
Insider ownership18.2%100
Financial Health w=15%73.4
Current ratio5.1100
Debt / equity0.3193.8
Interest coverage-1.2x0
Cash vs total debt2.52x100
Marketing & Brand w=10%83.9
Revenue growth (yoy)91.9%100
SG&A efficiency7.1x revenue/SG&A84.4
Brand pricing premium51.9%67.2
Momentumno data
News & Sentiment w=10%91.3
Analyst consensus (1=buy)1.790.3
Analyst target upside75.0%100
Earnings surprises (avg)+68.9%100
Headline tone5 pos / 3 neg of 1075
⚠ Red flags
Unprofitable (negative net income)
27 NVS US Novartis AG · 156.33 USD · pulse 60 first scan new 62.8 Good
Product & Moat w=20%88.8
Gross margin (pricing power)75.0%100
Revenue CAGR (3y)9.3%46.3
Operating margin trend+12.8pp over 3y100
R&D intensity (innovation)19.8%100
Margin stabilitysd 1.1pp97.5
Valuation w=20%55.4
Forward P/E15.888.4
PEG ratio3.490
FCF yield4.0%63.7
EV / EBITDA14.769.7
Management w=15%63.9
Return on equity30.3%100
Buybacks vs dilution-3.4%/yr share count100
Net debt / EBITDA1.855.2
Insider ownership0.0%0
FCF conversion0.85x net income64.4
Financial Health w=15%37.8
Current ratio0.95.2
Debt / equity1.1746.2
Interest coverage15.3x100
Cash vs total debt0.16x0
Marketing & Brand w=10%47.1
Revenue growth (yoy)0.8%3.2
SG&A efficiency4.3x revenue/SG&A38
Brand pricing premium75.0%100
Momentum w=10%68.6
Price vs 200-day MA+7.9%91.7
52-week range position85th pct94.3
6m strength vs S&P 500-9.0pp19.9
News & Sentiment w=10%42.9
Analyst consensus (1=buy)2.846.7
Analyst target upside-0.6%23.5
Earnings surprises (avg)+2.7%51.5
Headline tone2 pos / 2 neg of 1050
28 AMAT US Applied Materials, Inc. · 539.14 USD · pulse 66.2 first scan new 62.7 Good
Product & Moat w=20%63.8
Gross margin (pricing power)49.0%72.4
Revenue CAGR (3y)3.2%16.2
Operating margin trend-0.3pp over 3y46.7
R&D intensity (innovation)12.6%83.9
Margin stabilitysd 0.8pp100
Valuation w=20%30.6
Forward P/E31.640.5
PEG ratio1.2878.1
FCF yield0.7%3.8
EV / EBITDA46.00
Management w=15%61.6
Return on equity39.7%100
Buybacks vs dilution-2.1%/yr share count100
Net debt / EBITDA-0.1100
Insider ownership0.3%3.2
FCF conversion0.43x net income4.9
Financial Health w=15%91.5
Current ratio2.5100
Debt / equity0.3094.2
Interest coverage35.5x100
Cash vs total debt1.13x71.8
Marketing & Brand w=10%68.5
Revenue growth (yoy)11.4%45.6
SG&A efficiency16.0x revenue/SG&A100
Brand pricing premium49.0%59.9
Momentum w=10%90.7
Price vs 200-day MA+41.6%100
52-week range position68th pct72
6m strength vs S&P 500+55.6pp100
News & Sentiment w=10%84.7
Analyst consensus (1=buy)1.5100
Analyst target upside16.7%66.7
Earnings surprises (avg)+5.8%72
Headline tone4 pos / 0 neg of 10100
29 HSBC US HSBC Holdings, plc. · 103.73 USD · pulse 65.2 first scan new 61.2 Mixed
Product & Moat w=20%24.4
Gross margin (pricing power)0.0%0
Revenue CAGR (3y)9.8%48.8
Valuation w=20%94.2
Forward P/E11.0100
PEG ratio1.0588.4
Management w=15%50.8
Return on equity13.1%52.4
Buybacks vs dilution-5.0%/yr share count100
Insider ownership0.0%0
Financial Health w=15%96.6
Cash vs total debt1.46x96.6
Marketing & Brand w=10%55.2
Revenue growth (yoy)25.4%100
SG&A efficiency5.9x revenue/SG&A65.6
Brand pricing premium0.0%0
Momentum w=10%92.3
Price vs 200-day MA+22.8%100
52-week range position91th pct100
6m strength vs S&P 500+8.1pp76.9
News & Sentiment w=10%46
Analyst consensus (1=buy)2.753.3
Analyst target upside2.3%30.7
Earnings surprises (avg)-23.8%0
Headline tone1 pos / 0 neg of 10100
30 JNJ US Johnson & Johnson · 259.24 USD · pulse 61.2 first scan new 60.3 Mixed
Product & Moat w=20%77.4
Gross margin (pricing power)68.1%100
Revenue CAGR (3y)5.6%28
Operating margin trend+0.9pp over 3y59
R&D intensity (innovation)15.6%100
Margin stabilitysd 0.5pp100
Valuation w=20%41
Forward P/E21.172.5
PEG ratio4.210
FCF yield2.7%40
EV / EBITDA18.751.2
Management w=15%62.6
Return on equity25.7%100
Buybacks vs dilution-2.7%/yr share count100
Net debt / EBITDA0.879.7
Insider ownership0.0%0.5
FCF conversion0.63x net income32.8
Financial Health w=15%55.1
Current ratio1.124.1
Debt / equity0.5879.1
Interest coverage34.6x100
Cash vs total debt0.42x17.2
Marketing & Brand w=10%53.1
Revenue growth (yoy)6.6%26.4
SG&A efficiency4.0x revenue/SG&A33
Brand pricing premium68.1%100
Momentum w=10%80.2
Price vs 200-day MA+14.5%100
52-week range position92th pct100
6m strength vs S&P 500-2.8pp40.7
News & Sentiment w=10%65.2
Analyst consensus (1=buy)1.983.5
Analyst target upside5.1%37.8
Earnings surprises (avg)+1.0%39.7
Headline tone2 pos / 0 neg of 10100
31 PANW US Palo Alto Networks, Inc. · 363.86 USD · pulse 61.4 first scan new 60.2 Mixed
Product & Moat w=20%94.3
Gross margin (pricing power)72.0%100
Revenue CAGR (3y)18.8%93.9
Operating margin trend+16.9pp over 3y100
R&D intensity (innovation)21.5%100
Margin stabilitysd 2.1pp77.6
Valuation w=20%3.2
Forward P/E88.30
PEG ratio3.680
FCF yield1.2%12.9
EV / EBITDA199.20
Management w=15%46.1
Return on equity4.8%19.3
Buybacks vs dilution+3.8%/yr share count3.7
Net debt / EBITDA-0.7100
Insider ownership0.8%7.6
FCF conversion3.16x net income100
Financial Health w=15%75.4
Current ratio0.94.7
Debt / equity0.08100
Interest coverage840.8x100
Cash vs total debt1.46x97
Marketing & Brand w=10%70
Revenue growth (yoy)31.1%100
SG&A efficiency2.6x revenue/SG&A10
Brand pricing premium72.0%100
Momentum w=10%100
Price vs 200-day MA+66.8%100
52-week range position99th pct100
6m strength vs S&P 500+116.4pp100
News & Sentiment w=10%67
Analyst consensus (1=buy)1.696
Analyst target upside-6.7%8.2
Earnings surprises (avg)+7.1%80.4
Headline tone2 pos / 1 neg of 1083.3
32 CVX.TO CA CVX.TO · 23.84 CAD · pulse 58 first scan new 59.5 Mixed
Product & Moat w=20%40.2
Gross margin (pricing power)44.3%60.7
Revenue CAGR (3y)-7.9%0
Operating margin trend-7.9pp over 3y0
Margin stabilitysd 0.7pp100
Valuation w=20%66.4
Forward P/E596.00
PEG ratio0.67100
FCF yield4.6%74.2
EV / EBITDA9.991.3
Management w=15%69.7
Return on equity12.2%48.9
Buybacks vs dilution+1.4%/yr share count43.8
Net debt / EBITDA0.685.9
FCF conversion1.78x net income100
Financial Health w=15%60
Current ratio1.337.7
Debt / equity0.19100
Interest coverage17.2x100
Cash vs total debt0.23x2.3
Marketing & Brand w=10%82.7
Revenue growth (yoy)53.5%100
SG&A efficiency36.0x revenue/SG&A100
Brand pricing premium44.3%48.2
Momentum w=10%39.8
52-week range position57th pct58.6
6m strength vs S&P 500-8.7pp21
News & Sentiment w=10%50
Analyst consensus (1=buy)1.5100
Analyst target upside-96.4%0
Headline tone0 pos / 0 neg of 150
33 ORCL US ⚠ 2 Oracle Corporation · 147.02 USD · pulse 57.2 first scan new 59.2 Mixed
Product & Moat w=20%83.9
Gross margin (pricing power)65.8%100
Revenue CAGR (3y)10.5%52.4
Operating margin trend+5.7pp over 3y100
R&D intensity (innovation)15.3%100
Margin stabilitysd 2.6pp67.4
Valuation w=20%61.6
Forward P/E13.595.5
PEG ratio0.8398.6
FCF yield-5.8%0
EV / EBITDA18.552.2
Management w=15%46.6
Return on equity53.4%100
Buybacks vs dilution+2.0%/yr share count33.1
Net debt / EBITDA4.40
Insider ownership40.5%100
FCF conversion-1.44x net income0
Financial Health w=15%18.4
Current ratio1.126.2
Debt / equity3.890
Interest coverage5.3x47.2
Cash vs total debt0.19x0
Marketing & Brand w=10%87.3
Revenue growth (yoy)20.6%82.4
SG&A efficiency6.8x revenue/SG&A79.5
Brand pricing premium65.8%100
Momentum w=10%9.6
Price vs 200-day MA-17.5%0
52-week range position15th pct6.6
6m strength vs S&P 500-8.4pp22.1
News & Sentiment w=10%87
Analyst consensus (1=buy)1.598.2
Analyst target upside68.1%100
Earnings surprises (avg)+12.7%100
Headline tone2 pos / 2 neg of 1050
⚠ Red flags
Negative free cash flow
Heavy leverage (D/E 3.9)
34 AZN US AstraZeneca PLC · 161.42 USD · pulse 56.2 first scan new 58.9 Mixed
Product & Moat w=20%77.1
Gross margin (pricing power)81.7%100
Revenue CAGR (3y)9.8%49.1
Operating margin trend+12.5pp over 3y100
R&D intensity (innovation)24.2%100
Margin stabilitysd 4.2pp36.6
Valuation w=20%67.3
Forward P/E13.994.1
PEG ratio1.3375.8
FCF yield2.0%26.5
EV / EBITDA14.072.9
Management w=15%46.3
Return on equity22.0%87.9
Buybacks vs dilution+0.0%/yr share count66.3
Net debt / EBITDA1.465.6
Insider ownership0.0%0.5
FCF conversion0.48x net income11.4
Financial Health w=15%42
Current ratio0.97.2
Debt / equity0.6475.4
Interest coverage8.7x85.4
Cash vs total debt0.15x0
Marketing & Brand w=10%46.5
Revenue growth (yoy)6.4%25.6
SG&A efficiency2.8x revenue/SG&A13.8
Brand pricing premium81.7%100
Momentum w=10%10.1
Price vs 200-day MA-12.2%11.3
52-week range position25th pct19
6m strength vs S&P 500-27.5pp0
News & Sentiment w=10%83.5
Analyst consensus (1=buy)1.5100
Analyst target upside32.4%100
Earnings surprises (avg)+0.1%34.1
Headline tone2 pos / 0 neg of 10100
35 GEV US GE Vernova Inc. · 990.32 USD · pulse 65.1 first scan new 58.4 Mixed
Product & Moat w=20%44.9
Gross margin (pricing power)20.6%1.4
Revenue CAGR (3y)8.7%43.4
Operating margin trend+13.4pp over 3y100
R&D intensity (innovation)3.1%21
Margin stabilitysd 3.1pp58.9
Valuation w=20%43.7
Forward P/E39.915.5
PEG ratio1.6859.9
FCF yield6.0%99.3
EV / EBITDA65.20
Management w=15%75.4
Return on equity82.6%100
Buybacks vs dilution-0.6%/yr share count76
Net debt / EBITDA-2.3100
Insider ownership0.1%1.2
FCF conversion3.22x net income100
Financial Health w=15%74.9
Current ratio0.84.2
Debt / equity0.2895.4
Interest coverage14.2x100
Cash vs total debt3.42x100
Marketing & Brand w=10%60.8
Revenue growth (yoy)21.9%87.6
SG&A efficiency7.7x revenue/SG&A94.9
Brand pricing premium20.6%0
Momentum w=10%91.9
Price vs 200-day MA+17.1%100
52-week range position71th pct75.8
6m strength vs S&P 500+15.2pp100
News & Sentiment w=10%95.7
Analyst consensus (1=buy)1.696.8
Analyst target upside24.4%85.9
Earnings surprises (avg)+74.3%100
Headline tone1 pos / 0 neg of 10100
36 AAPL US Apple Inc. · 313.33 USD · pulse 59.3 first scan new 57.5 Mixed
Product & Moat w=20%58.7
Gross margin (pricing power)48.7%71.6
Revenue CAGR (3y)1.8%9.1
Operating margin trend+1.7pp over 3y66.8
R&D intensity (innovation)8.3%55.3
Margin stabilitysd 1.5pp90.6
Valuation w=20%26.7
Forward P/E32.936.6
PEG ratio2.4624.7
FCF yield2.4%33.7
EV / EBITDA27.412
Management w=15%78.7
Return on equity148.8%100
Buybacks vs dilution-2.5%/yr share count100
Net debt / EBITDA0.196.7
Insider ownership1.6%16.5
FCF conversion0.96x net income80.2
Financial Health w=15%56.5
Current ratio1.016.9
Debt / equity0.7867.5
Interest coverage33.8x100
Cash vs total debt0.74x41.5
Marketing & Brand w=10%74.9
Revenue growth (yoy)16.4%65.6
SG&A efficiency15.1x revenue/SG&A100
Brand pricing premium48.7%59.1
Momentum w=10%78.8
Price vs 200-day MA+12.3%100
52-week range position77th pct83.6
6m strength vs S&P 500+0.8pp52.8
News & Sentiment w=10%65.2
Analyst consensus (1=buy)2.176.5
Analyst target upside3.0%32.6
Earnings surprises (avg)+5.2%68.3
Headline tone2 pos / 1 neg of 1083.3
37 SHEL US Shell PLC · 88.5 USD · pulse 63.9 first scan new 56.2 Mixed
Product & Moat w=20%18.8
Gross margin (pricing power)26.1%15.2
Revenue CAGR (3y)-11.2%0
Operating margin trend-6.2pp over 3y0
R&D intensity (innovation)0.4%2.9
Margin stabilitysd 2.2pp75.7
Valuation w=20%93.9
Forward P/E10.0100
PEG ratio1.3475.5
FCF yield8.8%100
EV / EBITDA5.0100
Management w=15%67.9
Return on equity14.3%57.4
Buybacks vs dilution-6.7%/yr share count100
Net debt / EBITDA0.781.9
Insider ownership0.0%0
FCF conversion1.20x net income100
Financial Health w=15%57.3
Current ratio1.452.9
Debt / equity0.4088.8
Interest coverage7.3x69.7
Cash vs total debt0.43x17.6
Marketing & Brand w=10%67.6
Revenue growth (yoy)44.7%100
SG&A efficiency21.2x revenue/SG&A100
Brand pricing premium26.1%2.7
Momentum w=10%87.7
Price vs 200-day MA+9.8%99.3
52-week range position80th pct88
6m strength vs S&P 500+7.7pp75.7
News & Sentiment w=10%70.5
Analyst consensus (1=buy)2.270
Analyst target upside10.8%51.9
Earnings surprises (avg)+4.0%60.1
Headline tone4 pos / 0 neg of 10100
38 BABA US ⚠ 1 Alibaba Group Holding Limited · 128.41 USD · pulse 54.6 first scan new 55.7 Mixed
Product & Moat w=20%42.7
Gross margin (pricing power)39.8%49.5
Revenue CAGR (3y)5.6%28.1
Operating margin trend-6.0pp over 3y0
R&D intensity (innovation)6.5%43.3
Margin stabilitysd 1.4pp92.4
Valuation w=20%73.4
Forward P/E14.293.5
PEG ratio0.53100
FCF yield-14.3%0
EV / EBITDA3.0100
Management w=15%51
Return on equity9.2%36.9
Buybacks vs dilution-3.3%/yr share count100
Net debt / EBITDA-0.3100
Insider ownership1.8%18.3
FCF conversion-0.43x net income0
Financial Health w=15%77.1
Current ratio1.340.2
Debt / equity0.2597.2
Interest coverage14.2x100
Cash vs total debt1.12x71.1
Marketing & Brand w=10%25.5
Revenue growth (yoy)2.9%11.6
SG&A efficiency3.7x revenue/SG&A28
Brand pricing premium39.8%37
Momentum w=10%20.7
Price vs 200-day MA-7.6%29.5
52-week range position36th pct32.8
6m strength vs S&P 500-32.3pp0
News & Sentiment w=10%75
Analyst consensus (1=buy)1.3100
Analyst target upside48.0%100
Earnings surprises (avg)-38.4%0
Headline tone1 pos / 0 neg of 10100
⚠ Red flags
Negative free cash flow
39 TXN US Texas Instruments Incorporated · 286.08 USD · pulse 61 first scan new 55.4 Mixed
Product & Moat w=20%40.3
Gross margin (pricing power)58.3%95.8
Revenue CAGR (3y)-4.1%0
Operating margin trend-17.2pp over 3y0
R&D intensity (innovation)11.8%78.5
Margin stabilitysd 4.6pp27.4
Valuation w=20%39.1
Forward P/E27.553
PEG ratio1.2579.5
FCF yield1.4%15.6
EV / EBITDA28.28.3
Management w=15%58.9
Return on equity35.2%100
Buybacks vs dilution+0.0%/yr share count66.1
Net debt / EBITDA0.781.5
Insider ownership0.3%2.8
FCF conversion0.71x net income44.1
Financial Health w=15%72.7
Current ratio4.9100
Debt / equity0.7867.8
Interest coverage11.5x100
Cash vs total debt0.50x22.9
Marketing & Brand w=10%91.5
Revenue growth (yoy)22.8%91.2
SG&A efficiency9.5x revenue/SG&A100
Brand pricing premium58.3%83.3
Momentum w=10%93.9
Price vs 200-day MA+26.1%100
52-week range position75th pct81.6
6m strength vs S&P 500+18.5pp100
News & Sentiment w=10%68.9
Analyst consensus (1=buy)2.273.3
Analyst target upside13.4%58.5
Earnings surprises (avg)+9.0%93.6
Headline tone1 pos / 1 neg of 1050
40 CSCO US Cisco Systems, Inc. · 121.43 USD · pulse 60.1 first scan new 55.2 Mixed
Product & Moat w=20%62.8
Gross margin (pricing power)64.3%100
Revenue CAGR (3y)3.2%16
Operating margin trend-5.0pp over 3y0
R&D intensity (innovation)16.4%100
Margin stabilitysd 1.1pp97.9
Valuation w=20%38.3
Forward P/E25.359.6
PEG ratio1.6163.2
FCF yield1.9%26.2
EV / EBITDA29.14.1
Management w=15%67.4
Return on equity25.2%100
Buybacks vs dilution-1.2%/yr share count87.2
Net debt / EBITDA1.075.9
Insider ownership0.1%0.5
FCF conversion0.91x net income73.2
Financial Health w=15%46.2
Current ratio0.910.4
Debt / equity0.6873.6
Interest coverage8.0x77.4
Cash vs total debt0.50x23.4
Marketing & Brand w=10%60.2
Revenue growth (yoy)12.0%48
SG&A efficiency4.1x revenue/SG&A34.3
Brand pricing premium64.3%98.2
Momentum w=10%99
Price vs 200-day MA+34.7%100
52-week range position87th pct96.9
6m strength vs S&P 500+32.5pp100
News & Sentiment w=10%69.8
Analyst consensus (1=buy)1.886.2
Analyst target upside9.2%48
Earnings surprises (avg)+1.8%45.3
Headline tone4 pos / 1 neg of 10100
41 KO US Coca-Cola Company (The) · 87.05 USD · pulse 57.8 first scan new 55.1 Mixed
Product & Moat w=20%73.1
Gross margin (pricing power)61.9%100
Revenue CAGR (3y)3.7%18.4
Operating margin trend+3.1pp over 3y81
Margin stabilitysd 1.4pp92.8
Valuation w=20%26.5
Forward P/E24.761.6
PEG ratio4.220
FCF yield1.4%16.2
EV / EBITDA23.828.2
Management w=15%65.6
Return on equity42.1%100
Buybacks vs dilution-0.2%/yr share count70.1
Net debt / EBITDA1.659
Insider ownership9.9%98.9
FCF conversion0.40x net income0
Financial Health w=15%50.5
Current ratio1.342.1
Debt / equity1.1646.9
Interest coverage10.7x100
Cash vs total debt0.37x13.1
Marketing & Brand w=10%46.9
Revenue growth (yoy)6.7%26.8
SG&A efficiency3.3x revenue/SG&A21.7
Brand pricing premium61.9%92.2
Momentum w=10%82.9
Price vs 200-day MA+14.8%100
52-week range position92th pct100
6m strength vs S&P 500-0.4pp48.7
News & Sentiment w=10%75
Analyst consensus (1=buy)1.890
Analyst target upside8.8%47
Earnings surprises (avg)+4.5%63.2
Headline tone3 pos / 0 neg of 10100
42 MRK US Merck & Company, Inc. · 128.58 USD · pulse 57.8 first scan new 54.5 Mixed
Product & Moat w=20%75
Gross margin (pricing power)76.0%100
Revenue CAGR (3y)3.1%15.6
Operating margin trend+3.2pp over 3y81.7
R&D intensity (innovation)24.3%100
Margin stabilitysd 2.1pp77.8
Valuation w=20%41.3
Forward P/E13.495.8
PEG ratio11.850
EV / EBITDA23.828.2
Management w=15%36.6
Buybacks vs dilution-0.8%/yr share count80.6
Net debt / EBITDA2.928.5
Insider ownership0.1%0.6
Financial Health w=15%50.6
Debt / equity1.0751.7
Interest coverage16.5x100
Cash vs total debt0.12x0
Marketing & Brand w=10%62.7
Revenue growth (yoy)5.1%20.4
SG&A efficiency6.1x revenue/SG&A67.6
Brand pricing premium76.0%100
Momentum w=10%77.8
Price vs 200-day MA+15.3%100
52-week range position94th pct100
6m strength vs S&P 500-5.0pp33.3
News & Sentiment w=10%74.5
Analyst consensus (1=buy)1.887.1
Analyst target upside6.3%40.7
Earnings surprises (avg)+18.5%100
Headline tone3 pos / 2 neg of 1070
43 JPM US JP Morgan Chase & Co. · 357.52 USD · pulse 58.5 first scan new 54.3 Mixed
Product & Moat w=20%31.2
Gross margin (pricing power)0.0%0
Revenue CAGR (3y)12.5%62.5
Valuation w=20%75
Forward P/E14.393
PEG ratio1.7556.9
Management w=15%58.3
Return on equity17.8%71.2
Buybacks vs dilution-2.8%/yr share count100
Insider ownership0.4%3.9
Financial Health w=15%72
Cash vs total debt1.14x72
Marketing & Brand w=10%39.1
Revenue growth (yoy)30.4%100
SG&A efficiency3.0x revenue/SG&A17.2
Brand pricing premium0.0%0
Momentum w=10%83.3
Price vs 200-day MA+15.0%100
52-week range position98th pct100
6m strength vs S&P 500-0.1pp49.8
News & Sentiment w=10%54.8
Analyst consensus (1=buy)2.176.7
Analyst target upside4.6%36.4
Earnings surprises (avg)+3.4%56.2
Headline tone1 pos / 1 neg of 1050
44 XOM US ExxonMobil Holdings Corporation · 153.04 USD · pulse 60.5 first scan new 54.3 Mixed
Product & Moat w=20%28
Gross margin (pricing power)29.8%24.4
Revenue CAGR (3y)-6.7%0
Operating margin trend-5.6pp over 3y0
Margin stabilitysd 1.6pp87.4
Valuation w=20%88.6
Forward P/E14.592.5
PEG ratio1.2181.6
EV / EBITDA9.891.7
Management w=15%47.7
Return on equity12.6%50.3
Buybacks vs dilution+0.8%/yr share count53.6
Net debt / EBITDA0.588.3
Insider ownership0.1%0.8
FCF conversion0.72x net income45.2
Financial Health w=15%57.9
Current ratio1.127.9
Debt / equity0.16100
Interest coverage69.4x100
Cash vs total debt0.25x3.8
Marketing & Brand w=10%70.6
Revenue growth (yoy)44.1%100
SG&A efficiency29.1x revenue/SG&A100
Brand pricing premium29.8%11.9
Momentum w=10%68
Price vs 200-day MA+10.0%100
52-week range position75th pct80.6
6m strength vs S&P 500-8.0pp23.5
News & Sentiment w=10%75.1
Analyst consensus (1=buy)2.464
Analyst target upside9.6%49
Earnings surprises (avg)+8.1%87.6
Headline tone6 pos / 0 neg of 10100
45 BAC US Bank of America Corporation · 63.17 USD · pulse 62.1 first scan new 54.1 Mixed
Product & Moat w=20%15
Gross margin (pricing power)0.0%0
Revenue CAGR (3y)6.0%30
Valuation w=20%93.8
Forward P/E11.9100
PEG ratio1.0787.6
Management w=15%73.1
Return on equity11.2%44.8
Buybacks vs dilution-3.4%/yr share count100
Insider ownership7.5%74.6
Financial Health w=15%69.3
Cash vs total debt1.10x69.3
Marketing & Brand w=10%23.3
Revenue growth (yoy)16.8%67.2
SG&A efficiency2.2x revenue/SG&A2.7
Brand pricing premium0.0%0
Momentum w=10%84.4
Price vs 200-day MA+18.1%100
52-week range position100th pct100
6m strength vs S&P 500+0.9pp53.1
News & Sentiment w=10%82.3
Analyst consensus (1=buy)1.598.3
Analyst target upside8.9%47.2
Earnings surprises (avg)+7.5%83.6
Headline tone3 pos / 0 neg of 10100
46 ABBV US AbbVie Inc. · 246.04 USD · pulse 58.7 first scan new 53.2 Mixed
Product & Moat w=20%63.2
Gross margin (pricing power)72.8%100
Revenue CAGR (3y)1.8%8.8
Operating margin trend+0.4pp over 3y54.4
R&D intensity (innovation)14.9%99.1
Margin stabilitysd 3.3pp53.6
Valuation w=20%78.7
Forward P/E15.190.7
PEG ratio0.40100
FCF yield3.9%61.5
EV / EBITDA16.262.6
Management w=15%54
Buybacks vs dilution-0.0%/yr share count67.1
Net debt / EBITDA2.147.7
Insider ownership0.1%1.1
FCF conversion3.99x net income100
Financial Health w=15%8.7
Current ratio0.80.8
Interest coverage3.3x25.3
Cash vs total debt0.09x0
Marketing & Brand w=10%60.1
Revenue growth (yoy)10.2%40.8
SG&A efficiency4.4x revenue/SG&A39.4
Brand pricing premium72.8%100
Momentum w=10%77.2
Price vs 200-day MA+10.8%100
52-week range position76th pct82.2
6m strength vs S&P 500-0.2pp49.3
News & Sentiment w=10%71.9
Analyst consensus (1=buy)1.790.3
Analyst target upside11.1%52.8
Earnings surprises (avg)+1.7%44.6
Headline tone5 pos / 0 neg of 10100
47 PG US Procter & Gamble Company (The) · 145.79 USD · pulse 51.6 first scan new 52.9 Mixed
Product & Moat w=20%58.7
Gross margin (pricing power)50.9%77.2
Revenue CAGR (3y)2.0%10
Operating margin trend+0.6pp over 3y55.8
Margin stabilitysd 1.4pp92
Valuation w=20%52
Forward P/E19.776.7
PEG ratio5.710
FCF yield3.9%62.2
EV / EBITDA14.769.3
Management w=15%62.4
Return on equity30.3%100
Buybacks vs dilution-0.5%/yr share count75.7
Net debt / EBITDA1.074.7
Insider ownership0.1%0.7
FCF conversion0.83x net income61.1
Financial Health w=15%45.4
Current ratio0.70
Debt / equity0.6475.3
Interest coverage24.2x100
Cash vs total debt0.28x6.5
Marketing & Brand w=10%32.7
Revenue growth (yoy)1.5%6
SG&A efficiency3.6x revenue/SG&A27.3
Brand pricing premium50.9%64.7
Momentum w=10%30.8
Price vs 200-day MA-0.1%59.7
52-week range position36th pct32.8
6m strength vs S&P 500-19.0pp0
News & Sentiment w=10%68.9
Analyst consensus (1=buy)2.175.2
Analyst target upside10.2%50.6
Earnings surprises (avg)+2.5%49.9
Headline tone2 pos / 0 neg of 10100
48 PM US Philip Morris International Inc · 189.57 USD · pulse 55.7 first scan new 51.4 Mixed
Product & Moat w=20%66.6
Gross margin (pricing power)67.5%100
Revenue CAGR (3y)8.6%42.9
Operating margin trend-1.8pp over 3y31.8
Margin stabilitysd 1.4pp91.8
Valuation w=20%49.8
Forward P/E20.773.7
PEG ratio2.4624.5
FCF yield3.3%50.7
EV / EBITDA18.950.4
Management w=15%42.8
Buybacks vs dilution+0.1%/yr share count64.4
Net debt / EBITDA2.440.1
Insider ownership0.2%1.6
FCF conversion0.86x net income65.1
Financial Health w=15%37.4
Current ratio1.015
Interest coverage9.7x97.2
Cash vs total debt0.12x0
Marketing & Brand w=10%54.4
Revenue growth (yoy)10.4%41.6
SG&A efficiency3.3x revenue/SG&A21.5
Brand pricing premium67.5%100
Momentum w=10%72.8
Price vs 200-day MA+12.5%100
52-week range position82th pct90.3
6m strength vs S&P 500-6.5pp28.2
News & Sentiment w=10%76.8
Analyst consensus (1=buy)1.890
Analyst target upside7.5%43.8
Earnings surprises (avg)+6.0%73.4
Headline tone3 pos / 1 neg of 10100
49 TD.TO CA ⚠ 1 TORONTO-DOMINION BANK · 169.3 CAD · pulse 57.2 first scan new 51.2 Mixed
Product & Moat w=20%25.6
Gross margin (pricing power)0.0%0
Revenue CAGR (3y)10.2%51.1
Valuation w=20%88.7
Forward P/E15.788.7
Management w=15%49.4
Return on equity11.9%47.6
Buybacks vs dilution-2.5%/yr share count100
Insider ownership0.0%0.4
Financial Health w=15%78.4
Cash vs total debt1.22x78.4
Marketing & Brand w=10%2
Revenue growth (yoy)-31.5%0
SG&A efficiency2.4x revenue/SG&A6
Brand pricing premium0.0%0
Momentum w=10%100
Price vs 200-day MA+22.7%100
52-week range position92th pct100
6m strength vs S&P 500+18.1pp100
News & Sentiment w=10%49.8
Analyst consensus (1=buy)2.273.8
Analyst target upside-3.7%15.7
Earnings surprises (avg)+3.9%59.6
Headline tone1 pos / 1 neg of 1050
⚠ Red flags
Revenue shrinking (-31.5% yoy)
50 RY.TO CA ROYAL BANK OF CANADA · 294.59 CAD · pulse 57.8 first scan new 50.8 Mixed
Product & Moat w=20%27.3
Gross margin (pricing power)0.0%0
Revenue CAGR (3y)10.9%54.5
Valuation w=20%57.8
Forward P/E16.785.7
PEG ratio2.3429.9
Management w=15%42
Return on equity16.2%64.8
Buybacks vs dilution+0.3%/yr share count60.9
Insider ownership0.0%0.3
Financial Health w=15%100
Cash vs total debt1.64x100
Marketing & Brand w=10%26.3
Revenue growth (yoy)16.1%64.4
SG&A efficiency2.9x revenue/SG&A14.6
Brand pricing premium0.0%0
Momentum w=10%100
Price vs 200-day MA+22.2%100
52-week range position93th pct100
6m strength vs S&P 500+16.2pp100
News & Sentiment w=10%68.7
Analyst consensus (1=buy)2.174.3
Analyst target upside-6.0%10
Earnings surprises (avg)+8.6%90.4
Headline tone4 pos / 1 neg of 10100
51 DELL US Dell Technologies Inc. · 453.77 USD · pulse 60.2 first scan new 50.8 Mixed
Product & Moat w=20%39.4
Gross margin (pricing power)19.2%0
Revenue CAGR (3y)3.5%17.7
Operating margin trend+1.8pp over 3y68
R&D intensity (innovation)2.8%18.4
Margin stabilitysd 1.4pp92.8
Valuation w=20%58.2
Forward P/E20.873.4
PEG ratio0.66100
FCF yield1.9%24.6
EV / EBITDA22.434.7
Management w=15%78.1
Buybacks vs dilution-3.1%/yr share count100
Net debt / EBITDA1.463.8
Insider ownership7.5%74.9
FCF conversion0.92x net income73.6
Financial Health w=15%25.5
Current ratio0.912.2
Interest coverage5.7x51.7
Cash vs total debt0.36x12.5
Marketing & Brand w=10%66.7
Revenue growth (yoy)87.5%100
SG&A efficiency10.2x revenue/SG&A100
Brand pricing premium19.2%0
Momentum w=10%100
Price vs 200-day MA+105.2%100
52-week range position96th pct100
6m strength vs S&P 500+264.6pp100
News & Sentiment w=10%85.2
Analyst consensus (1=buy)1.888.9
Analyst target upside10.8%52
Earnings surprises (avg)+20.1%100
Headline tone3 pos / 1 neg of 10100
52 BMO.TO CA BANK OF MONTREAL · 253.24 CAD · pulse 57.2 first scan new 50 Mixed
Product & Moat w=20%28
Gross margin (pricing power)0.0%0
Revenue CAGR (3y)11.2%56
Valuation w=20%75.9
Forward P/E15.589.3
PEG ratio1.6362.5
Management w=15%28.9
Return on equity11.4%45.5
Buybacks vs dilution+1.5%/yr share count41
Insider ownership0.0%0.3
Financial Health w=15%90.6
Cash vs total debt1.38x90.6
Marketing & Brand w=10%25.6
Revenue growth (yoy)15.8%63.2
SG&A efficiency2.8x revenue/SG&A13.6
Brand pricing premium0.0%0
Momentum w=10%100
Price vs 200-day MA+26.1%100
52-week range position97th pct100
6m strength vs S&P 500+20.9pp100
News & Sentiment w=10%58.9
Analyst consensus (1=buy)2.751.4
Analyst target upside-7.7%5.7
Earnings surprises (avg)+6.8%78.5
Headline tone3 pos / 0 neg of 10100
53 CNR.TO CA CANADIAN NATIONAL RAILWAY CO. · 176.52 CAD · pulse 55.6 first scan new 49.1 Mixed
Product & Moat w=20%55.7
Gross margin (pricing power)56.0%89.9
Revenue CAGR (3y)0.4%1.9
Operating margin trend-1.9pp over 3y30.8
Margin stabilitysd 0.9pp100
Valuation w=20%49.9
Forward P/E19.676.9
PEG ratio2.837.9
FCF yield2.8%42.4
EV / EBITDA14.172.2
Management w=15%57.6
Return on equity22.0%88.1
Buybacks vs dilution-3.0%/yr share count100
Net debt / EBITDA2.538.6
Insider ownership2.7%27
FCF conversion0.64x net income34.5
Financial Health w=15%33.9
Current ratio0.95.9
Debt / equity1.0453.4
Interest coverage7.9x76.2
Cash vs total debt0.01x0
Marketing & Brand w=10%40.9
Revenue growth (yoy)11.3%45.2
SG&A efficiency-36.1x revenue/SG&A0
Brand pricing premium56.0%77.4
Momentum w=10%99
Price vs 200-day MA+19.0%100
52-week range position88th pct97.1
6m strength vs S&P 500+16.9pp100
News & Sentiment w=10%67.6
Analyst consensus (1=buy)2.369.3
Analyst target upside7.7%44.2
Earnings surprises (avg)+3.5%56.8
Headline tone7 pos / 0 neg of 10100
54 ENB.TO CA ⚠ 1 ENBRIDGE INC · 71.55 CAD · pulse 35.3 first scan new 29.2 Weak
Product & Moat w=20%46.7
Gross margin (pricing power)32.6%31.5
Revenue CAGR (3y)6.9%34.7
Operating margin trend+2.3pp over 3y73.3
Margin stabilitysd 3.6pp47.1
Valuation w=20%33.2
Forward P/E22.269
PEG ratio5.770
FCF yield-0.7%0
EV / EBITDA15.964
Management w=15%12.6
Return on equity9.2%36.9
Buybacks vs dilution+2.5%/yr share count24.7
Net debt / EBITDA6.30
Insider ownership0.1%1.3
FCF conversion-0.14x net income0
Financial Health w=15%10.6
Current ratio0.70
Debt / equity1.6320.6
Interest coverage3.0x21.8
Cash vs total debt0.02x0
Marketing & Brand w=10%39.7
Revenue growth (yoy)97.1%100
SG&A efficiency-482.9x revenue/SG&A0
Brand pricing premium32.6%19
Momentum w=10%50.9
Price vs 200-day MA+1.0%64.1
52-week range position55th pct55.9
6m strength vs S&P 500-5.2pp32.7
News & Sentiment w=10%67.6
Analyst consensus (1=buy)2.559.1
Analyst target upside12.1%55.4
Earnings surprises (avg)+3.4%56
Headline tone6 pos / 0 neg of 10100
⚠ Red flags
Negative free cash flow